Prednisolone Tapering Guidelines for Pediatric Patients

Initial Dosing and Tapering Schedule

The American Association for the Study of Liver Diseases recommends starting with prednisolone 1-2 mg/kg/day, with a practical maximum of 60 mg daily as a single morning dose 1, 2
For a 46.3 kg patient, the recommended starting dose would be 46-60 mg daily 1, 2
Administer as a single daily dose in the morning to minimize adrenal suppression 2
Maintain initial high dose for at least 1 month, then taper by reducing 25-33% at 2-week intervals down to 15 mg daily, followed by 2.5 mg reductions every 2 weeks to 10 mg daily, and finally 1 mg decrements every 2-4 weeks until discontinuation 1, 2, 5, 6
The European Association for the Study of the Liver recommends reducing by 10 mg every 2 weeks until reaching 30 mg daily, then by 5 mg every 2 weeks from 30 mg to 20 mg daily, and finally by 2.5 mg every 2 weeks from 20 mg to 10 mg daily 6
The tapering approach should be gradual and response-guided, with monitoring for clinical response and normalization of laboratory parameters 5, 6

The American Academy of Pediatrics recommends early introduction of a steroid-sparing agent, such as azathioprine 1-2 mg/kg/day or 6-mercaptopurine 1.5 mg/kg/day, to minimize effects on linear growth, bone development, and cosmesis 1, 2
Some centers advocate rapid switch to alternate-day dosing, 1.5 mg/kg every other day, maximum 40 mg, after initial response to reduce growth retardation 1, 2
Monitor for steroid-specific side effects, including weight gain, cushingoid features, behavioral changes, and bone health 1, 7
Baseline and annual bone mineral density testing should be considered for long-term therapy 4

Do not taper too rapidly, as rapid tapering increases relapse risk, particularly when reducing from doses above 15 mg daily 6, 8
Do not use doses too low to be effective, as inadequate initial dosing leads to treatment failure 8
Do not continue high doses unnecessarily, as prolonged high-dose therapy significantly increases severe side effects in children 4
If relapse occurs during taper, return to the last dose that controlled symptoms, maintain for 2-3 weeks, then resume slower tapering 8

For non-cirrhotic patients with certain conditions, budesonide 9 mg daily may be considered as an alternative with fewer systemic side effects, though it has 90% first-pass hepatic metabolism and should not be used in cirrhotic patients 1, 6